Numerous malignancies, including leukemia, brain cancer, colorectal adenocarcinoma and hepatocellular carcinoma, have been linked to increased expression of Hspa9 [43,44,45,46]. This evidence concerns the gene HSPA9 and colorectal adenocarcinoma.